Latest News about Chris Shibutani
Recent news which mentions Chris Shibutani
Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst
January 23, 2025
From Benzinga
Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug
August 09, 2024
From Benzinga
Is Bristol-Myers Squibb's Stock Rally Justified? Bull Vs. Bear Analysts On Q2 Earnings
July 29, 2024
Tickers
BMY
From Benzinga
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
February 12, 2024
From Benzinga
This Pfizer Analyst Is Turning Bullish Citing 'Pipeline Progress And M&A Activity'
December 13, 2022
Tickers
PFE
From Benzinga